Economy
Best Hospitals for Thymus Cancer Worldwide
According to the American Association of Oncologists, thymus cancer is rare and accounts for about 0.5% of all tumors. The illness does not show any signs at the initial stage but, at the same time, has a high potential for malignancy. It is characterized by rapid growth and metastasis.
Over the years, we have accumulated statistics on the leading hospitals in Europe and the US for treating thymus cancer. And we can recommend to patients exactly where they will be treated most effectively. So keep reading, and we will share with you the necessary information.
Criteria for selecting the best hospitals for thymus cancer
Not only an error-free diagnosis and the results of further treatment but sometimes life itself depends on the correct choice of the treatment center and attending physician. Therefore, it is necessary to collect all possible information in order not to be disappointed in the chosen hospital in the future:
- Hospitals specialization. It is essential in the treatment of advanced cases of thymus cancer.
- It is necessary to look at clinic articles, scientific developments, and the introduction of various treatment methods for thymus cancer.
- Information about oncologists and thoracic surgeons who work in this hospital.
- It would be good to get acquainted with the reviews of specialists in this field but not working in this clinic.
- It is advisable to choose several hospitals and compare them.
- The second opinion is an opportunity to verify the accuracy of the diagnosis, to hear an alternative point of view of an experienced specialist, or to learn about alternative treatment options.
Finding a hospital with the online service AiroMedical is fast, simple, and effective. It is enough to specify the doctor’s specialty or the disease’s symptoms in the search bar to find the right specialist. Then, in a few seconds, the system will provide you with a relevant list of the hospitals.
Top hospitals for thymus cancer treatment in the United States
University Hospitals Michigan Ann Arbor
Langone Hospital New York
Wisconsin University Hospitals Madison
Benefits of Medical Treatment in the US
Several essential advantages of the list of hospitals in the US:
- Reliable diagnosis, the accuracy of which determines the choice of a treatment plan and the effectiveness of the procedures.
- Hybrid operating rooms, the latest microsurgical and minimally invasive operations equipment.
- World-class thoracic surgeons who are proficient in all modern methods.
Top hospitals for thymus cancer treatment in Europe
University Hospital Frankfurt, Germany
Marien Hospital Marl, Germany
Teknon Medical Centre, Spain
Anadolu Medical Centre, Turkey
Benefits of medical treatment in Europe
European medicine offers the most current opportunities for timely thymus cancer detection and comprehensive diagnosis. Treatment in hospitals in Europe is also:
- World leadership in the number of scientific papers and discoveries in medicine.
- Use of unique developments and author’s methods.
- Careful monitoring of compliance with international standards at all stages of manipulation.
Top hospitals for thymus cancer treatment in Poland
Medicover Hospital Warsaw
European Health Center Otwock
Gamma Knife Exira Center Katowice
Benefits of medical treatment in Poland
Advantages of Polish cancer treatment:
- Fast and accurate examination, low-traumatic technologies.
- Complex treatment, including thymus surgery, chemo, and radiotherapy.
- Remote consultations with doctors after completion of therapy.
Top hospitals for thymus cancer treatment in Italy
University Hospital San Raffaele Milan
European Oncology Institute Milan
Agostino Gemelli University Policlinic Rome
Benefits of medical treatment in Italy
A whole list of hospitals in Italy has such advantages:
- The best doctors with extensive experience treating thymus tumors.
- Diagnostics are carried out on innovative equipment that provides 100% accuracy of results.
- Healthcare costs are more affordable than in America, and the quality is not inferior.
Top hospitals for thymus cancer treatment in Germany
Helios Clinic Berlin-Buch
University Hospital Charite
University Hospital Heidelberg
Benefits of medical treatment in Germany
Several advantages of hospitals in Germany:
- Hybrid operating rooms, robot-assisted surgery.
- Close cooperation of German thoracic surgeons with many narrow specialists.
- Pediatric thoracic surgeons and oncologists are at the disposal of young patients.
Best thymus cancer doctors worldwide
The best doctors in thymus cancer treatment:
Prof. Dr. med. Maximilian Bockhorn
Dr. med. habil. Krzysztof Wrobel
Prof. Dr. Thomas Vogl
Prof. Dr. Hans Hoffmann
Prof. Dr. Helmut Friess
Best treatment solutions for treating thymus cancer
Doctors of the best hospitals in the US and Europe treat thymus cancer using conservative methods and surgically, taking advantage of the latest oncology achievements that allow achieving success in more than 90% of cases. You can read more about each treatment method for thymus cancer on our website.
Here we will mention only a few:
- Da Vinci’s robotic thymectomy. Minimally invasive surgery through four small incisions for the video camera and the robot’s “hands.” The system provides an accurate 3D image of the operating field and the accuracy of movements inaccessible to humans.
- Ablation. A needle-like electrode is inserted into the patient, and an electric current is applied. It leads to a local increase in tissue temperature and the destruction of cancer cells.
- Brachytherapy. It is the irradiation of the tumor with radioactive isotopes from the inside. Unique seeds with an active substance are injected directly into the cancer tissue with the help of endoscopic equipment.
- Targeted therapy. Angiogenesis inhibitors (drugs that prevent the formation of blood vessels) and growth factor inhibitors are most often used.
How to get treatment in the best clinics for thymus cancer
Some diagnoses divide a person’s life into “before” and “after.” You can’t be prepared for them; they sound unfair and scary. Every day in our work, we encounter people tired of endless, fruitless trips to doctors who have almost lost hope of recovery. And how nice it is to see how people’s attitudes to life change after the first positive treatment results.
The AiroMedical project aims to help people who are faced with thymus cancer. On our platform, you will find:
- Consultations of leading oncologists, information about the features of diagnosis and thymus cancer treatment.
- Hospital contacts and appointments for diagnostics and treatment without queues and tedious waiting.
- New therapy methods are used only in a few cancer centers.
Treating thymus cancer with AiroMedical is an opportunity to entrust your health to the best oncologist, constantly improving their professional skills. So leave us a request and get a personalized treatment program.
References
- Semenchuk O. Thymus cancer treatment. AiroMedical. Updated January, 2023. https://airomedical.com/search/thymus-cancer-tymoma
- Kyiashko D. Thymus cancer guide. AiroMedical. Updated March 22, 2023. https://airomedical.com/blogs/disease-guides/thymus-cancer-guide
- Yuan Z., Gao S., Mu J., Xue Q., Mao Y. Long-term outcomes of 307 patients after complete thymoma resection. National library of medicine. Published May 15, 2017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433013/
By Adedapo Adesanya
NASD Over-the-Counter (OTC) Securities Exchange remained in the negative territory after it further depreciated by 0.64 per cent on Friday, July 24, despite recording four price gainers.
The NASD Security Index (NSI) dropped 27.4 points at the close of business to settle at 4,294.75 points versus the previous day’s 4,383.48 points, while the market capitalisation gave up N16.49 billion to end at N2.577 trillion, in contrast to the N2.594 trillion it ended a day earlier.
The bourse was down during the session amid heavy sell-offs, with the volume of transactions skyrocketing by 693.9 per cent to 2.99 million units from Thursday’s 377,635 units.
Equally, the value of trades went up by 71.6 per cent to N69.4 million from N40.4 million, and the number of deals increased by 41.0 per cent to 55 deals from the preceding day’s 39 deals.
Great Nigeria Insurance (GNI) Plc remained the most active stock by value on a year-to-date basis, with 3.4 billion units worth N8.4 billion, trailed by Infrastructure Credit Guarantee (Infracredit) Plc with 2.3 billion units sold for N6.5 billion, and Central Securities Clearing System (CSCS) Plc with 75.6 million units traded for N5.4 billion.
GNI Plc was also the most active stock by volume on a year-to-date basis, with 3.4 billion units exchanged for N8.4 billion, trailed by Infracredit Plc with 2.3 billion units transacted for N6.5 billion, and Resourcery Plc with 1.1 billion units valued at N415.7 million.
The market ended the session with four price gainers and two price losers, led by FrieslandCampina Wamco Nigeria Plc, which lost N7.44 to trade at N136.19 per share compared with the previous day’s N143.63 per share, and CSCS Plc, which declined by N1.64 to N93.63 per unit from N95.27 per unit.
But MRS Oil gained N13.50 to sell at N148.50 per share versus N135.00 per share, Afriland Properties Plc advanced by 56 Kobo to N17.41 per unit from N16.85 per unit, UBN Property Plc surged by 18 Kobo to N1.93 per share from N1.75 per share, and Food Concepts Plc climbed by 1 Kobo to N2.50 per unit from N2.49 per unit.
By Dipo Olowookere
Nigeria’s stock exchange succumbed to profit-taking on Friday, losing 0.19 per cent when the closing gong was hit at 4 pm.
Shares in the banking and energy sectors influenced the decline suffered by the Nigerian Exchange (NGX) Limited during the session, as they respectively closed lower by 0.40 per cent and 0.04 per cent.
The industrial goods index was flat yesterday, while the insurance counter gained 0.68 per cent and the consumer goods space chalked up 0.25 per cent. The gains by these two segments could not keep Customs Street in the green territory at the close of business.
As a result, the All-Share Index (ASI) retreated by 474.00 points to 247,357.40 points from 247,831.40 points, and the market capitalisation decreased by N306 billion to N159.588 trillion from N159.894 trillion.
Presco dropped 10.00 per cent during the trading day to close at N2,070.00, Thomas Wyatt crumbled by 9.93 per cent to N3.63, Trans-Nationwide Express plunged by 8.44 per cent to N2.82, Royal Exchange slipped by 7.86 per cent to N1.29, and LivingTrust Mortgage Bank shrank by 7.32 per cent to N3.80.
On the flip side, C&I Leasing improved by 9.48 per cent to N6.35, Cornerstone Insurance rose by 9.09 per cent to N6.00, RT Briscoe jumped by 8.61 per cent to N13.25, Honeywell Flour expanded by 7.38 per cent to N17.45, and Africa Prudential increased by 6.98 per cent to N13.80.
Despite the poor performance, the local bourse recorded a positive market breadth index after finishing with 35 price gainers and 25 price losers, representing strong investor sentiment.
It was a relatively quiet market on Friday, as the activity level dropped, with the trading volume down by 27.72 per cent to 565.5 million units from 782.4 million units, and the trading value contracted by 46.89 per cent to N29.9 billion from N56.3 billion, while the number of deals executed by investors soared by 16.03 per cent to 53,688 deals from 46,273 deals.
Access Holdings was the busiest stock for the session, with a turnover of 128.0 million units sold for N3.8 billion, First Holdco transacted 35.4 million units worth N4.3 billion, Chams exchanged 34.8 million units valued at N154.3 million, Zenith Bank traded 30.4 million units for N3.9 billion, and UBA sold 30.4 million units worth N1.5 billion.
By Adedapo Adesanya
The Naira marked a whole week of appreciation against the United States Dollar on Friday, July 24, further gaining N5.67 or 0.41 per cent to close at N1,362.09/$1 in the Nigerian Autonomous Foreign Exchange Market (NAFEX) compared with N1,367.76/$1 it ended on Thursday.
Equally, the local currency appreciated against the Pound Sterling in the official FX market yesterday by N10.83 to trade at N1,813.62/£1 versus the preceding day’s N1,824.45/£1, and improved against the Euro by N7.68 to settle at N1,549.10/€1, in contrast to the N1,556.78/€1 it was exchanged a day earlier.
However, at the parallel market and GTBank forex counter, the Nigerian currency remained unchanged against the greenback during the session at N1,400/$1 and N1,379/$1, respectively.
The Central Bank of Nigeria (CBN) buffer has been strengthened with sustained foreign portfolio inflows and robust foreign reserves, which stand above $52 billion.
The apex bank’s policy signals that the Naira will be stronger in the near term, with Nigeria clearing hurdles with FX reforms and settlement of all backlogs.
However, some traders expect that pressure may come due to foreign-currency buying from fuel importers as they make Dollar purchases to build inventories.
Meanwhile, Bitcoin (BTC), in the digital currency landscape, trimmed recent gains as it fell by 2.3 per cent to $63,787.73.
The weak action in the AI momentum trade is feeding through to crypto as well.
Further, Cardano (ADA) dropped 3.7 per cent to close at $0.1615, Solana (SOL) dipped by 2.8 per cent to $73.71, Ripple (XRP) crashed by 2.3 per cent to $1.08, Ethereum (ETH) slid by 1.9 per cent to $1,851.58, Dogecoin (DOGE) retreated by 0.8 per cent to $0.0694, Binance Coin (BNB) contracted by 0.7 per cent to $564.18, and TRON (TRX) lost 0.5 per cent to trade at $0.3292, while the US Dollar Tether (USDT) and the US Dollar Coin (USDC) traded flat at $1.00 each.
